Stem Cell Implants, a San Diego, CA-based provider of biotechnology dental implant, raised an undisclosed amount in Seed funding.
The backers were not disclosed.
The company intends to use the funds to advance the field of dentistry with stem cell biotechnology.
Led by Allan Dovigi DDS MS, CEO, Stem Cell Implants leverages stem cell biotechnology to advance dental implants. Founded in 2023, the company has developed the patented Pre-Osseointegrated Implant, which features:
- Unlimited amounts of bone and soft tissue can be custom-made and formed in vitro for grafting.
- No risk of immune rejection or disease transmission.
- Quicker, more predicate stem cell-based healing.
The startup is building its team and roadmapping regulatory approval.
FinSMEs
13/12/2023